Efficacy of Kangliuwan for Recurrent Grade IV Glioma

NCT03949192 · clinicaltrials.gov ↗
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Xuanwu Hospital, Beijing